Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CHAT | P28329 | 2/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3654206 | 1.00 | MAOB (0.46) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL7519973 | 1.00 | MAOB (0.46) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL27372971 | 0.97 | MAOB (0.43) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL28054656 | 0.85 | ALDH1A1 (0.41) | ALDH1A1LMNAMAPK1L3MBTL1TDP1 | |
| SCHEMBL6330351 | 0.82 | MAOB (0.56) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL6330348 | 0.82 | MAOB (0.56) | MAOBALDH1A1TSHRCYP2A6TRPA1 | |
| SCHEMBL3949316 | 0.77 | — | — | |
| SCHEMBL627659 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 | |
| SCHEMBL9454821 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 | |
| SCHEMBL21457949 | 0.76 | MAOB (0.74) | MAOBALDH1A1TRPA1LMNAALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2786985-A2 | Antagonists of the glucagon receptor | Metabasis Therapeutics, Inc. (US) | 2014-10-08 | — | — | EP | claimed |
| JP-4216713-B2 | — | — | 2009-01-28 | — | — | JP | claimed |
| EP-1404324-A4 | PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF | XENOPORT INC (US) | 2004-12-22 | — | — | EP | claimed |
| JP-2004536873-A | — | — | 2004-12-09 | — | — | JP | claimed |
| EP-1404324-A2 | PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF | Xenoport, Inc. (US) | 2004-04-07 | — | — | EP | claimed |
| WO-2002100347-A2 | PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF | XENOPORT, INC. (US) | 2002-12-19 | — | — | WO | claimed |
| US-12017980-B2 | Monofunctional phenolic compound, active ester resin and method for producing the same, and thermosetting resin composition and cured product thereof | DIC CORPORATION (JP) | 2024-06-25 | — | — | US | disclosed |
| US-11993617-B2 | Organic luminescent material having an ancillary ligand with a partially fluorine-substituted substituent | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2024-05-28 | — | — | US | disclosed |
| US-20230144101-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-11466026-B2 | Organic electroluminescent materials and devices | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-10-11 | — | — | US | disclosed |
| US-20220033333-A1 | MONOFUNCTIONAL PHENOLIC COMPOUND, ACTIVE ESTER RESIN AND METHOD FOR PRODUCING THE SAME, AND THERMOSETTING RESIN COMPOSITION AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2022-02-03 | — | — | US | disclosed |
| US-10807946-B2 | Antagonists of the glucagon receptor | METABASIS THERAPEUTICS, INC. (US) | 2020-10-20 | — | — | US | disclosed |
| WO-2020059625-A1 | PHENOL COMPOUND, ACTIVE ESTER RESIN, PRODUCTION METHOD FOR ACTIVE ESTER RESIN, THERMOSETTING RESIN COMPOSITION, AND CURED PRODUCT OF THERMOSETTING RESIN COMPOSITION | DIC株式会社 | 2020-03-26 | — | — | WO | disclosed |
| WO-2000066588-A1 | DIRECT C-14 OXIDATION OF OPIOIDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENTOF HEALTH A ND HUMAN SERVICES (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000020441-A2 | CYCLIC PEPTIDES AS ANTIFUNGAL AGENTS | ABBOTT LABORATORIES (US) | 2000-04-13 | — | — | WO | disclosed |
| US-5017724-A | Antihypoxic, CNS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| EP-0267024-B1 | HYDROFLUORENE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | EP | disclosed |
| EP-0321155-A2 | Ethylenically-unsaturated ethers of alkenyl phenols as reactive diluents for bismaleimides | AMOCO CORPORATION (US) | 1989-06-21 | — | — | EP | disclosed |
| US-4812511-A | FIBER REINFORCED COMPOSITES | AMOCO CORPORATION (US) | 1989-03-14 | — | — | US | disclosed |
| EP-0267024-A2 | Hydrofluorene derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11993617-B2 | Organic luminescent material having an ancillary ligand with a partially fluorine-substituted substituent | KCNK10, KCNQ1, KCNK2 | MAOB 403/4885ALDH1A1 1128/4885TSHR 2734/4885 |
| US-11466026-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, SLCO4C1 | MAOB 699/4885ALDH1A1 1580/4885TSHR 4433/4885 |
| US-12017980-B2 | Monofunctional phenolic compound, active ester resin and method for producing the same, and thermosetting resin composition and cured product thereof | JMJD7, KDM7A, KDM4A | MAOB 1149/4885ALDH1A1 474/4885TSHR 4809/4885 |
| US-20220033333-A1 | MONOFUNCTIONAL PHENOLIC COMPOUND, ACTIVE ESTER RESIN AND METHOD FOR PRODUCING THE SAME, AND THERMOSETTING RESIN COMPOSITION AND CURED PRODUCT THEREOF | JMJD7, KDM7A, KDM4A | MAOB 1149/4885ALDH1A1 474/4885TSHR 4809/4885 |
| US-10807946-B2 | Antagonists of the glucagon receptor | GLP1R, GCGR, GPR119 | MAOB 3523/4885ALDH1A1 4657/4885TSHR 64/4885 |
| US-20230144101-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | TRPC4, CRY1, TRPC1 | MAOB 4062/4885ALDH1A1 2910/4885TSHR 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.